We are pleased to announce that the Joint "Rapid relative effectiveness assessment of new pharmaceuticals for the treatment of chronic Hepatitis C" og WP5-SA6 is now available.
We are pleased to announce that the 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is available.
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Structured telephone support (STS) for adult patients with chronic heart failure”
With the preparation of the Joint Action 3 on HTA switching into high gear, confirmation of the immediate practical relevance of the HTA activities are coming in - both from the national and larger European level events of the recent days.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is expecting as many as 5000 participants in its 18th Annual European Congress in Milan, Italy.